VPS26B

Across TCGA pan-cancer cohorts, VPS26B Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated VPS26B data layer compared with 26 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher VPS26B Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated VPS26B expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

COAD, LUSC, and HNSC are the cancer types where VPS26B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.500	0.871	<.001	24	view →
LUSC	OS	Median	All	0.173	0.724	.012	15	view →
HNSC	OS	Median	All	0.099	0.768	<.001	12	view →
LUAD	OS	Median	All	0.338	0.834	.007	12	view →
UCEC	DFS	Median	All	1.000	0.634	.022	8	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

VPS26B–COAD (OS)

Open the COAD breakdown →